Your browser doesn't support javascript.
Pfizer's Idea Orchard
Pharmaceutical Technology Europe ; 34(9):9-12, 2022.
Article in English | ProQuest Central | ID: covidwho-20243212
ABSTRACT
Recognizing reality, Uwe Schoenbeck, PhD, senior vice president and chief scientific officer for Emerging Science & Innovation (ES&I) at Pfizer, has synthesized and made functional core lessons from two of the past decade's best business books According to Schoenbeck, ESLs are highly experienced in the relevant disease area and embedded within the respective therapeutic areas, resulting in high strategic alignment of the opportunity being sourced and avoiding opportunities that are not a strategic fit (1). The ES&I team, in conjunction with colleagues working in Business Development, has stood out for bringing genuinely creative partnership ideas and innovations into an already creative and crowded environment. [...]a collaboration with Codex DNA will potentially streamline the mRNA production process by facilitating synthetic DNA assembly, another notable fruit of the team's labour to bring forth a competitive pipeline in gene therapy.
Keywords
Search on Google
Collection: Databases of international organizations Database: ProQuest Central Language: English Journal: Pharmaceutical Technology Europe Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Collection: Databases of international organizations Database: ProQuest Central Language: English Journal: Pharmaceutical Technology Europe Year: 2022 Document Type: Article